hiPSC-derived cardiomyocytes (epicardial delivery)

human induced pluripotent stem cell-derived cardiomyocytes · HELP Therapeutics Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for hiPSC-derived cardiomyocytes (epicardial delivery), covering 2026-02-10 to 2026-02-10. Get the full timeline:

Most recent: Clinical Trial Update: Epicardial Injection of hiPSC-CMs to Treat Severe Chronic Ischemic Heart Failure [Phase 1, Phase 2]

See pricing